AIRNA to Present New Preclinical Data on RNA-Editing Therapeutic Pipeline at ASGCT Annual Meeting

CAMBRIDGE, Mass., April 28, 2026 – AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, will present new preclinical data from the company’s pipeline of RNA-editing therapeutics, including lead candidate AIR-001 and the company’s cardiometabolic portfolio, at the 2026 Annual Meeting of the American Society of […] The post AIRNA to Present New Preclinical Data on RNA-Editing Therapeutic Pipeline at ASGCT Annual Meeting appeared first on Airna .